e-NIOS is a partner of the “INNOCENT” consortium (Slovakia, Greece, Norway, Spain, Latvia, ), funded by a EuroNanoMed II ERA-NET grant, aiming at the development of innovative multifunctional nanopharmaceuticals for breast cancer treatment, with emphasis on cancer stem cells.